References
- Abbasi, A., et al., 2017. Near-infrared responsive gold-layersome nanoshells. Langmuir: The ACS Journal of Surfaces and Colloids, 33 (21), 5321–5327. Available from: 10.1021/acs.langmuir.7b01273
- Acevedo-Fani, A. and Singh, H., 2022. Biophysical insights into modulating lipid digestion in food emulsions. Progress in lipid research, 85, 101129. Available from: https://linkinghub.elsevier.com/retrieve/pii/S016378272100045X
- Aiswarya, M.U., et al., 2019. Cryptosomes: a revolutionary breakthrough in novel drug delivery. International journal of applied pharmaceutics, 11 (1), 7. Available from: https://innovareacademics.in/journals/index.php/ijap/article/view/29077
- Akbarzadeh, A., et al., 2013. Liposome: classification, preparation, and applications. Nanoscale research letters, 8 (1), 102. Available from: 10.1186/1556-276X-8-102
- Akhlaquer Rahman, M., et al., 2011. Oral lipid based drug delivery system (LBDDS): formulation, characterization and application: a review. Current drug delivery, 8 (4), 330–345. Available from: http://www.eurekaselect.com/openurl/content.php?genre=article&issn=1567-2018&volume=8&issue=4&spage=330
- Akhtar, N., et al., 2020. Liposome-based drug delivery of various anticancer agents of synthetic and natural product origin: a patent overview. Pharmaceutical patent analyst, 9 (3), 87–116. Available from: 10.4155/ppa-2019-0020
- Ali, G.A.A., 2017. Pharmacosomes: an updated review. Universal journal of pharmaceutical research, 2 (1), 33–36. Available from: http://ujpr.org/index.php/journal/article/view/114
- Allahou, L.W., Madani, S.Y., and Seifalian, A., 2021. Investigating the application of liposomes as drug delivery systems for the diagnosis and treatment of cancer. International journal of biomaterials, 2021, 1–16. Available from: https://www.hindawi.com/journals/ijbm/2021/3041969/
- Allen, T.M. and Cleland, L.G., 1980. Serum-induced leakage of liposome contents. Biochimica et biophysica acta (BBA)-biomembranes, 597 (2), 418–426. Available from: https://linkinghub.elsevier.com/retrieve/pii/0005273680901182
- Allen, T.M., 1998. Liposomal drug formulations. Drugs, 56 (5), 747–756. Available from: 10.2165/00003495-199856050-00001
- Almeida, A. and Souto, E., 2007. Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Advanced drug delivery reviews, 59 (6), 478–490. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0169409X07000439
- Ambati, S., et al., 2019a. Dectin-2-targeted antifungal liposomes exhibit enhanced efficacy. mSphere, 4 (5), 1-16. Available from: http://www.ncbi.nlm.nih.gov/pubmed/31666315
- Ambati, S., et al., 2019b. Dectin-1-targeted antifungal liposomes exhibit enhanced efficacy. mSphere, 4 (1), 1-15. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30760610
- Ambati, S., et al., 2022. DectiSomes: glycan targeting of liposomal drugs improves the treatment of disseminated candidiasis. Antimicrobial agents and chemotherapy, 66 (1), 1-13. Available from: 10.1128/AAC.01467-21
- Anselmo, A.C. and Mitragotri, S., 2019. Nanoparticles in the clinic: an update. Bioengineering & translational medicine, 4 (3), 1-16. Available from: 10.1002/btm2.10143
- Anwar, E., and Farhana, N., 2018. Formulation and evaluation of phytosome-loaded maltodextrin-gum Arabic microsphere system for delivery of Camellia sinensis extract. Journal of young pharmacists, 10 (2s), S56–S62. Available from: https://www.jyoungpharm.org/article/1226
- Aslam Abdul Rahiman, C.A., et al., 2021. Novasome: a pioneering advancementin vesicular drug delivery. International journal of applied pharmaceutics, 13(1), 59–64. Available from: https://innovareacademics.in/journals/index.php/ijap/article/view/39528
- Authority H Product Regulatory, n.d. Available from: http://www.hpra.ie/img/uploaded/swedocuments/LicenseSPC_PA1329-009-001_11082014151041.pdf
- Babazadeh, A., Jafari, S. M., and Shi, B., 2019. Encapsulation of food ingredients by nanophytosomes. In: Lipid-based nanostructures for food encapsulation purposes. Sidney, Australia : Elsevier, 405–443. Available from: https://linkinghub.elsevier.com/retrieve/pii/B9780128156735000106
- Baer, E., 1965. From the trioses to the synthesis of natural phospholipids: a research trial of forty years. Journal of the American oil chemists' society, 42 (4), 257–266. Available from: 10.1007/BF02540126
- Bakker-Woudenberg, I.A.J.M., Storm, G., and Woodle, M.C., 1994. Liposomes in the treatment of infections. Journal of drug targeting, 2 (5), 363–371. Available from: 10.3109/10611869408996811
- Banerjee, A., Roychoudhury, J., and Ali, N., 2008. Stearylamine-bearing cationic liposomes kill Leishmania parasites through surface exposed negatively charged phosphatidylserine. The journal of antimicrobial chemotherapy, 61 (1), 103–110. Available from: 10.1093/jac/dkm396
- Bansal, S., et al., 2012. A comparative review on vesicular drug delivery system and stability issues.
- Barenholz, Y. and Thompson, T.E., 1999. Sphingomyelin: biophysical aspects. Chemistry and physics of lipids, 102 (1–2), 29–34. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0009308499000729
- Barriga, H.M.G., Holme, M.N., and Stevens, M.M., 2019. Cubosomes: the next generation of smart lipid nanoparticles? Angewandte chemie, 58 (10), 2958–2978. Available from: 10.1002/anie.201804067
- Battaglia, L., et al., 2016. Application of lipid nanoparticles to ocular drug delivery. Expert opinion on drug delivery, 13 (12), 1743–1757. Available from: 10.1080/17425247.2016.1201059
- Bertin, S., et al., 2007. [Naked DNA and lipoplexes applications in cancer gene therapy]. Bulletin du cancer, 94 (3), 243–252. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17371766
- Bhalaria, M.K., Naik, S., and Misra, A.N., 2009. Ethosomes: a novel delivery system for antifungal drugs in the treatment of topical fungal diseases. Indian journal of experimental biology, 47 (5), 368–375. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19579803
- Bhambere, D., et al., 2015. Lyophilization/freeze drying – a review. World journal of pharmaceutical research, 4, 516–543.
- Bhattacharyya, S., Adhikari, H., and Regmi, D., 2019. A brief review on QbD approach on liposome and the requirements for regulatory approval. Research journal of pharmacy and technology, 12 (8), 4057. Available from: http://www.indianjournals.com/ijor.aspx?target=ijor:rjpt&volume=12&issue=8&article=089
- Bolko, K., Zvonar, A., and Gašperlin, M., 2014. Simulating the digestion of lipid-based drug delivery systems (LBDDS): overview of in vitro lipolysis models. Acta chimica slovenica, 61 (1), 1–10. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24664320
- Bolla, P.K., et al., 2019. Clotrimazole loaded ufosomes for topical delivery: formulation development and in-vitro studies. Molecules, 24 (17), 293139. Available from: https://www.mdpi.com/1420-3049/24/17/3139
- Boyer, C. and Zasadzinski, J.A., 2007. Multiple lipid compartments slow vesicle contents release in lipases and serum. ACS nano, 1 (3), 176–182. Available from: 10.1021/nn7002025
- Brouwers, J., Brewster, M.E., and Augustijns, P., 2009. Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability? Journal of pharmaceutical sciences, 98 (8), 2549–2572. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0022354916330271
- Budai, L., et al., 2007. Gels and liposomes in optimized ocular drug delivery: studies on ciprofloxacin formulations. International journal of pharmaceutics, 343 (1–2), 34–40. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0378517307003316
- Budai, L., et al., 2013. Liposomes for topical use: a physico-chemical comparison of vesicles prepared from egg or soy lecithin. Scientia pharmaceutica, 81 (4), 1151–1166. Available from: http://www.mdpi.com/2218-0532/81/4/1151
- Budowski, C., et al., 2021. Early tolerability of Comirnaty vaccine in patients with chronic neurological diseases. Revue neurologique, 177 (10), 1262–1265. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0035378721006524
- Bulbake, U., et al., 2017. Liposomal formulations in clinical use: an updated review. Pharmaceutics, 9 (4), 12. Available from: http://www.mdpi.com/1999-4923/9/2/12
- Bummer, P.M., 2004. Physical chemical considerations of lipid-based oral drug delivery–solid lipid nanoparticles. Critical reviews in therapeutic drug carrier systems, 21 (1), 1–20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15099183
- Bunjes, H. and Unruh, T., 2007. Characterization of lipid nanoparticles by differential scanning calorimetry, X-ray and neutron scattering⋆. Advanced drug delivery reviews, 59 (6), 379–402. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0169409X07000361
- Cannon, J.B., 2008. Chemical and physical stability considerations for lipid-based drug formulations. American pharmaceutical review, 11(1), 132–138.
- Carreira, A.C., et al., 2019. Mammalian sphingoid bases: biophysical, physiological and pathological properties. Progress in lipid research, 75, 100988. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0163782718300651
- Cevc, G. and Blume, G., 2001. New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transfersomes. Biochimica et biophysica acta (BBA)-biomembranes, 1514 (2), 191–205. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0005273601003698
- Chambin, O. and Jannin, V., 2005. Interest of multifunctional lipid excipients: case of Gelucire 44/14. Drug development and industrial pharmacy, 31 (6), 527–534. Available from: 10.1080/03639040500215750
- Chang, T.M.S., 2003. Future generations of red blood cell substitutes. Journal of internal medicine, 253 (5), 527–535. Available from: 10.1046/j.1365-2796.2003.01151.x
- Charcosset, C., et al., 2015. Preparation of liposomes at large scale using the ethanol injection method: effect of scale-up and injection devices. Chemical engineering research and design, 94, 508–515. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0263876214004092
- Chauhan, B., Shimpi, S., and Paradkar, A., 2005a. Preparation and evaluation of glibenclamide-polyglycolized glycerides solid dispersions with silicon dioxide by spray drying technique. European journal of pharmaceutical sciences, 26 (2), 219–230. Available from: https://linkinghub.elsevier.com/retrieve/pii/S092809870500196X
- Chauhan, B., Shimpi, S., and Paradkar, A., 2005b. Preparation and characterization of etoricoxib solid dispersions using lipid carriers by spray drying technique. AAPS PharmSciTech, 6 (3), E405–E409. Available from: 10.1208/pt060350
- Chaurasiya, P., et al., 2019. Transfersomes: a novel technique for transdermal drug delivery. Journal of drug delivery and therapeutics, 9 (1), 279–285. Available from: http://jddtonline.info/index.php/jddt/article/view/2198
- Chemin, C., et al., 2009. Supramolecular organization of S12363-liposomes prepared with two different remote loading processes. Biochimica et biophysica acta (BBA)-biomembranes, 1788 (5), 926–935. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0005273608003799
- Chen, M.-L., 2008. Lipid excipients and delivery systems for pharmaceutical development: A regulatory perspective. Advanced drug delivery reviews, 60 (6), 768–777. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0169409X07003195
- Chime, A., 2013. Lipid-based drug delivery systems (LDDS): recent advances and applications of lipids in drug delivery. African journal of pharmacy and pharmacology, 7 (48), 3034–3059. Available from: http://academicjournals.org/journal/AJPP/article-abstract/8F6384E42625
- Chouhan, N., et al., 2015. Self-emulsifying drug delivery system (SEDDS) for phytoconstituents: a review. Current drug delivery, 12 (2), 244–253. Available from: http://www.eurekaselect.com/openurl/content.php?genre=article&issn=1567-2018&volume=12&issue=2&spage=244
- Ciobanu, M., et al., 2007. Layersome: development and optimization of stable liposomes as drug delivery system. International journal of pharmaceutics, 344 (1–2), 154–157. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0378517307004668
- Cliff, R.O., Kwasiborski, V., and Rudolph, A.S., 1995. A comparative study of the accurate measurement of endotoxin in liposome-encapsulated hemoglobin. Artificial cells, blood substitutes, and immobilization biotechnology, 23 (3), 331–336. Available from: 10.3109/10731199509117949
- Cócera, M., et al., 2000. Influence of the level of cholesteryl sulfate in the solubilization of stratum corneum lipid liposomes by sodium dodecyl sulfate. Colloid and polymer science, 278 (8), 794–799. Available from: 10.1007/s003960000336
- Collins, J.J. and Phillips, M.C., 1982. The stability and structure of cholesterol-rich codispersions of cholesterol and phosphatidylcholine. Journal of lipid research, 23 (2), 291–298. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7077143
- Constantinides, P.P. and Wasan, K.M., 2007. Lipid formulation strategies for enhancing intestinal transport and absorption of P-glycoprotein (P-gp) substrate drugs: in vitro/in vivo case studies. Journal of pharmaceutical sciences, 96 (2), 235–248. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0022354916321815
- Constantinides, P.P., Chaubal, M.V., and Shorr, R., 2008. Advances in lipid nanodispersions for parenteral drug delivery and targeting. Advanced drug delivery reviews, 60 (6), 757–767. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0169409X07003183
- Crew, M., 2014. Bioavailability enhancement – analysis of the historical use of solubilization technologies. Drug development & delivery. 14(2), 22.
- Cristiano, M.C., et al., 2021. Oleuropein-laded ufasomes improve the nutraceutical efficacy. Nanomaterials, 11 (1), 105. Available from: https://www.mdpi.com/2079-4991/11/1/105
- CSIR, 2019. Cationic liposome-encapsulated camptothecin (CPT) with DOX, enhanced anticancer efficacy in synergistic action to improve the therapeutic index. United States; US10426728B2.
- Cui, F., et al., 2007. Preparation of insulin loaded PLGA-Hp55 nanoparticles for oral delivery. Journal of pharmaceutical sciences, 96 (2), 421–427. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0022354916321955
- Cullis, P.R., et al., 1989. Generating and loading of liposomal systems for drug-delivery applications. Advanced drug delivery reviews, 3 (3), 267–282. Available from: https://linkinghub.elsevier.com/retrieve/pii/0169409X89900240
- Cullis, P.R., Hope, M.J., and Tilcock, C.P.S., 1986. Lipid polymorphism and the roles of lipids in membranes. Chemistry and physics of lipids, 40 (2–4), 127–144. Available from: https://linkinghub.elsevier.com/retrieve/pii/0009308486900678
- Cuppoletti, J., et al., 1981. Erythrosomes: large proteoliposomes derived from crosslinked human erythrocyte cytoskeletons and exogenous lipid. Proceedings of the national academy of sciences of the United States of America, 78 (5), 2786–2790. Available from: 10.1073/pnas.78.5.2786
- Dahan, A. and Hoffman, A., 2008. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs. Journal of controlled release, 129 (1), 1–10. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0168365908001624
- Dai, J. and Mumper, R.J., 2010. Plant phenolics: extraction, analysis and their antioxidant and anticancer properties. Molecules, 15 (10), 7313–7352. Available from: http://www.mdpi.com/1420-3049/15/10/7313
- Dammak, I., et al., 2020. Nanoemulsions: using emulsifiers from natural sources replacing synthetic ones–a review. Comprehensive reviews in food science and food safety, 19 (5), 2721–2746. Available from: 10.1111/1541-4337.12606
- Daraee, H., et al., 2016. Application of liposomes in medicine and drug delivery. Artificial cells, nanomedicine, and biotechnology, 44 (1), 381–391. Available from: 10.3109/21691401.2014.953633
- Davis, J.H. and Schmidt, M.L., 2014. Critical behaviour in DOPC/DPPC/cholesterol mixtures: static 2H NMR line shapes near the critical point. Biophysical journal, 106 (9), 1970–1978. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0006349514003397
- de Jonge, M.J.A., et al., 2010. Early cessation of the clinical development of LiPlaCis, a liposomal cisplatin formulation. European journal of cancer, 46 (16), 3016–3021. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0959804910006933
- Decome, L., et al., 2005. Evaluation of photolyase (Photosome®) repair activity in human keratinocytes after a single dose of ultraviolet B irradiation using the comet assay. Journal of photochemistry and photobiology B: biology, 79 (2), 101–108. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1011134404002131
- Deeba, F., et al., 2005. Phospholipid diversity: correlation with membrane–membrane fusion events. Biochimica et biophysica acta (BBA)-biomembranes, 1669 (2), 170–181. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0005273605000465
- Dhiman, A., et al., 2012. Potential phytotherapeutic agents in design of ethosomes: a review.
- Ding, B.-S., et al., 2006. Advanced drug delivery systems that target the vascular endothelium. Molecular interventions, 6 (2), 98–112. Available from: 10.1124/mi.6.2.7
- Dokania, S. and Joshi, A.K., 2015. Self-microemulsifying drug delivery system (SMEDDS)-challenges and road ahead. Drug delivery, 22 (6), 675–690. Available from: 10.3109/10717544.2014.896058
- Driscoll, D.F., 2006. Lipid injectable emulsions: pharmacopeial and safety issues. Pharmaceutical research, 23 (9), 1959–1969. Available from: 10.1007/s11095-006-9092-4
- Drummond, D.C., et al., 2019. Stabilizing camptothecin pharmaceutical compositions. United States; US10456360B2.
- Düzgüneş, N., et al., 1981. Calcium- and magnesium-induced fusion of mixed phosphatidylserine/phosphatidylcholine vesicles: effect of ion binding. The journal of membrane biology, 59 (2), 115–125. Available from: 10.1007/BF01875709
- Ecker, J. and Liebisch, G., 2014. Application of stable isotopes to investigate the metabolism of fatty acids, glycerophospholipid and sphingolipid species. Progress in lipid research, 54, 14–31. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0163782714000034
- El-Bacha, T. and Torres, A.G., 2016. Phospholipids: physiology. In: Encyclopedia of food and health. Federal University of Rio de Janeiro, Rio de Janeiro, Brazil: Elsevier, 352–359. Available from: https://linkinghub.elsevier.com/retrieve/pii/B9780123849472005407
- EMA. n.d.-a. Available from: https://www.ema.europa.eu/en/documents/product-information/comirnaty-epar-product-information_en.pdf
- EMA, n.d.-b. Available from: https://www.ema.europa.eu/en/documents/product-information/vyxeos-liposomal-epar-product-information_en.pdf.
- EMA, n.d.-c. Available from: https://www.medicines.org.uk/emc/product/2535/smpc
- EMA, n.d.-d. Summary of product characteristics. Available from: https://www.ema.europa.eu/en/documents/product-information/onivyde-pegylated-liposomal-epar-product-information_en.pdf
- EMA, n.d.-e. Summary for the public. Available from: https://www.ema.europa.eu/en/documents/overview/mepact-epar-summary-public_en.pdf
- EMA, n.d.-f. Summary of product characteristics. Available from: https://www.ema.europa.eu/en/documents/product-information/mepact-epar-product-information_en.pdf
- EMA, n.d.-g. Available from: https://www.ema.europa.eu/en/documents/product-information/aptivus-epar-product-information_en.pdf
- EMA, n.d.-h. Available from: https://www.ema.europa.eu/en/documents/referral/isotretinoin-article-29-referral-annex-i-ii-iii_en.pdf
- EMA, n.d.-i. Available from: https://www.ema.europa.eu/en/documents/product-information/kaletra-epar-product-information_en.pdf
- EMA, n.d.-j. Available from: https://www.ema.europa.eu/en/documents/product-information/targretin-epar-product-information_en.pdf
- EMA, n.d.-k. Summary of product characteristics. Available from: https://www.ema.europa.eu/en/documents/product-information/myocet-liposomal-previously-myocet-epar-product-information_en.pdf
- EMA, n.d.-l. Scientific discussion. Available from: https://www.ema.europa.eu/en/documents/scientific-discussion/myocet-epar-scientific-discussion_en.pdf.
- Erickson, M., 2008. Chemistry and function of phospholipids. Available from: 10.1201/9781420046649.ch2
- Farzaneh, H., et al., 2018. A study on the role of cholesterol and phosphatidylcholine in various features of liposomal doxorubicin: from liposomal preparation to therapy. International journal of pharmaceutics, 551 (1–2), 300–308. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0378517318307075
- Fathima, K.M., et al., 2016. Sphingosome vescicular system. International journal of pharmaceutics sciences review and research, 41, 208–213.
- Fatouros, D.G., et al., 2007. Clinical studies with oral lipid based formulations of poorly soluble compounds. Therapeutics and clinical risk management, 3 (4), 591–604. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18472981
- Faustino, P., 2020. Lipid systems for the delivery of amphotericin B in antifungal therapy. Pharmaceutics, 12 (1), 29. Available from: https://www.mdpi.com/1999-4923/12/1/29
- FDA and CDER, 2014. Guidance for industry CMC postapproval manufacturing changes to be documented in annual reports.
- FDA and CDER, 2018. Liposome drug products chemistry, manufacturing, and controls; human pharmacokinetics and bioavailability; and labeling documentation.
- FDA and CDER, 2021. Liposome drug products: chemistry, manufacturing, and controls; human pharmacokinetics and bioavailability; and labeling documentation. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/liposome-drug-products-chemistry-manufacturing-and-controls-human-pharmacokinetics-and
- FDA Application, n.d. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/anda/2000/065003_gengraf_toc.cfm#:∼:text=ApprovalDate%3A05%2F12%2F2000
- FDA, 2021. CFR-Code of Federal Regulations Title 21. Available from: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm?fr=201.57
- FDA, 2022. Available from: https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm.
- FDA, CDER, and CBER, 1999. Guidance for industry population pharmacokinetics.
- FDA, et al., 2011. Guidance for industry process validation: general principles and practices. Available from: https://www.fda.gov/files/drugs/published/Process-Validation–General-Principles-and-Practices.pdf
- FDA, n.d.-a. Available from: https://www.fda.gov/news-events/fda-brief/fda-brief-fda-approves-new-use-exparel-nerve-block-pain-relief-following-shoulder-surgeries#:∼:text=The%20U.S.%20Food%20and%20Drug,following%20shoulder%20surgery%20in%20adults
- FDA, n.d.-b. https://www.medicines.org.uk/emc/product/11802/smpc.
- FDA, n.d.-c. Highlights of prescribing information. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202497s011lbl.pdf.
- FDA, n.d.-d. Prescribing information. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021039s017lbl.pdf
- FDA, n.d.-e. Summary of product characteristics. Available from: https://www.ema.europa.eu/en/documents/product-information/norvir-epar-product-information_en.pdf
- FDA, n.d.-f. Highlights of prescribing information. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/050718s029lbl.pdf
- FDA, n.d.-g. Available from: https://www.fda.moph.go.th/sites/drug/Summary/1C_91_50_NC_Epaxal.pdf
- Fernández-García, R., et al., 2020. Transferosomes as nanocarriers for drugs across the skin: quality by design from lab to industrial scale. International journal of pharmaceutics, 573, 118817. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0378517319308622
- Forssen, E.A., 1997. The design and development of DaunoXome® for solid tumor targeting in vivo. Advanced drug delivery reviews, 24 (2–3), 133–150. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0169409X9600453X
- Fud, D., et al., 2017. Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors. International journal of nanomedicine, 12, 7291–7309. Available from: https://www.dovepress.com/effective-use-of-nanocarriers-as-drug-delivery-systems-for-the-treatme-peer-reviewed-article-IJN
- Gangwar, M., et al., 2012. Recent advances in various emerging vescicular systems: an overview. Asian Pacific journal of tropical biomedicine, 2 (2), S1176–S1188. Available from: http://linkinghub.elsevier.com/retrieve/pii/S2221169112603815
- García-Arribas, A.B., Goñi, F.M., and Alonso, A., 2021. Lipid self-assemblies under the atomic force microscope. International journal of molecular sciences, 22 (18), 10085. Available from: https://www.mdpi.com/1422-0067/22/18/10085
- Garg, G., Saraf, S., and Saraf, S., 2007. Cubosomes: an overview. Biological & pharmaceutical bulletin, 30 (2), 350–353. Available from: https://www.jstage.jst.go.jp/article/bpb/30/2/30_2_350/_article
- Gaspar, M., et al., 2003. Design and characterization of enzymosomes with surface-exposed superoxide dismutase. Biochimica et biophysica acta (BBA)-biomembranes, 1609 (2), 211–217. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0005273602007022
- Gershkovich, P., et al., 2007. Different impacts of intestinal lymphatic transport on the oral bioavailability of structurally similar synthetic lipophilic cannabinoids: dexanabinol and PRS-211,220. European journal of pharmaceutical sciences, 31 (5), 298–305. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0928098707001236
- Gilead Sciences Inc., n.d. Available from: https://www.gilead.com/∼/media/Files/pdfs/medicines/other/ambisome/ambisome_pi.pdf
- Gill, B., et al., 2012. Emulsomes: an emerging vesicular drug delivery system. Asian journal of pharmaceutics, 6 (2), 87. Available from: http://www.asiapharmaceutics.info/text.asp?2012/6/2/87/102930
- Gonzalez Gomez, A., et al., 2019. Liposomal nanovesicles for efficient encapsulation of staphylococcal antibiotics. ACS omega, 4 (6), 10866–10876. Available from: 10.1021/acsomega.9b00825
- Gould-Fogerite, S., 1998. Targeting immune response induction with cochleate and liposome-based vaccines. Advanced drug delivery reviews, 32 (3), 273–287. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0169409X98000143
- Goyal, S., et al., 2018. The interaction of human pathogenic fungi with C-type lectin receptors. Frontiers in immunology, 9, 1261. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29915598
- Grove, M., et al., 2006. Bioavailability of seocalcitol. European journal of pharmaceutical sciences, 28 (3), 233–242. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0928098706000480
- Grumezescu, A.M., 2019. Biomedical applications of nanoparticles. University Politehnica of Bucharest, Bucharest, Romania: Elsevier. Available from: https://linkinghub.elsevier.com/retrieve/pii/C20170044579
- Guo, L., et al., 2011. Preliminary evaluation of a novel oral delivery system for rhPTH1-34: in vitro and in vivo. International journal of pharmaceutics, 420 (1), 172–179. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0378517311007915
- Haas, M., et al., 2019. Liposomal formulations of lipophilic compounds. US; US 10, 413, 511 B2. Available from: https://patentimages.storage.googleapis.com/3f/a4/4f/e87b4a8f5ea062/US10413511.pdf
- Hammad, M. and Müller, B., 1998. Increasing drug solubility by means of bile salt–phosphatidylcholine-based mixed micelles. European journal of pharmaceutics and biopharmaceutics, 46 (3), 361–367. Available from: https://linkinghub.elsevier.com/retrieve/pii/S093964119800037X
- Han, I., et al., 2002. Liposome formulations for effective administration of lipophilic malonatoplatinum(II) complexes. Japanese journal of cancer research, 93 (11), 1244–1249. Available from: 10.1111/j.1349-7006.2002.tb01230.x
- Hannun, Y.A. and Obeid, L.M., 2018. Sphingolipids and their metabolism in physiology and disease. Nature reviews molecular cell biology, 19 (3), 175–191. Available from: http://www.nature.com/articles/nrm.2017.107
- Hattori, Y., et al., 2005. The role of dioleoylphosphatidylethanolamine (DOPE) in targeted gene delivery with mannosylated cationic liposomes via intravenous route. Journal of controlled release, 108 (2–3), 484–495. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0168365905003640
- Hauss, D.J., 2007. Oral lipid-based formulations. Advanced drug delivery reviews, 59 (7), 667–676. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0169409X07000853
- Hauss, D.J., et al., 1998. Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor. Journal of pharmaceutical sciences, 87 (2), 164–169. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0022354915505029
- Health Canada, n.d. Available from: https://www.canada.ca/content/dam/phac-aspc/documents/services/diseases/2019-novel-coronavirus-infection/awareness-resources/components-covid-19-vaccines/components-covid-19-vaccines-eng.pdf
- Hecker, J.G., 2016. Non-viral, lipid-mediated DNA and mRNA gene therapy of the central nervous system (CNS): chemical-based transfection, 307–324. Available from: 10.1007/978-1-4939-3271-9_23
- Hermansson, M., Hokynar, K., and Somerharju, P., 2011. Mechanisms of glycerophospholipid homeostasis in mammalian cells. Progress in lipid research, 50 (3), 240–257. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0163782711000063
- Higashi, Y. and Saito, K., 2019. Lipidomic studies of membrane glycerolipids in plant leaves under heat stress. Progress in lipid research, 75, 100990. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0163782719300335
- Hintzen, F., et al., 2014. In vivo evaluation of an oral self-microemulsifying drug delivery system (SMEDDS) for leuprorelin. International journal of pharmaceutics, 472 (1–2), 20–26. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0378517314003949
- Holm, R., 2003. Examination of oral absorption and lymphatic transport of halofantrine in a triple-cannulated canine model after administration in self-microemulsifying drug delivery systems (SMEDDS) containing structured triglycerides. European journal of pharmaceutical sciences, 20 (1), 91–97. Available from: https://linkinghub.elsevier.com/retrieve/pii/S092809870300174X
- Hong, S.-S., Kim, S.H., and Lim, S.-J., 2015. Effects of triglycerides on the hydrophobic drug loading capacity of saturated phosphatidylcholine-based liposomes. International journal of pharmaceutics, 483 (1–2), 142–150. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0378517315001088
- Hoogevest, P. and Luciani, P., 2018. Recent advances in the use of phospholipid excipients in local or injectable depot formulations. Pharmazeutische industrie, 80, 1104–1110.
- Hoogevest, P., 2020. Non‐aqueous phospholipid concentrates for increasing the bioavailability of poorly soluble compounds. European journal of lipid science and technology, 122 (6), 1900411. Available from: 10.1002/ejlt.201900411
- Hoogevest, P., et al., 2021. The use of phospholipids to make pharmaceutical form line extensions. European journal of lipid science and technology, 123 (4), 2000297. Available from: 10.1002/ejlt.202000297
- Hua, S. and Wu, S.Y., 2013. The use of lipid-based nanocarriers for targeted pain therapies. Frontiers in pharmacology, 4, 143. Available from: 10.3389/fphar.2013.00143/abstract
- Hua, S., 2013. Targeting sites of inflammation: intercellular adhesion molecule-1 as a target for novel inflammatory therapies. Frontiers in pharmacology, 4, 127. Available from: 10.3389/fphar.2013.00127/abstract
- Hua, S., et al., 2015. Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue. Nanomedicine: nanotechnology, biology, and medicine, 11 (5), 1117–1132. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1549963415000684
- Huang, Z., et al., 2014. Progress involving new techniques for liposome preparation. Asian journal of pharmaceutical sciences, 9 (4), 176–182. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1818087614000336
- Hunt, C.A. and McCasland, G.E., 1985. Liposome technology, vol. 1: preparation of liposomes; vol. 2: incorporation of drugs, proteins, and genetic materials; vol. 3: targeted drug delivery and biological interaction. Journal of pharmaceutical sciences, 74 (7), 802. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0022354915467437
- ICH, 2003. Stability testing of new drug substances and products ICH Q1A(R2). ICH Harmonised Tripartite Guideline.
- Idris, N., et al., 2014. Erythrosomes: large proteoliposomes derived from crosslinked human erythrocyte cytoskeletons and exogenous lipid. Austin journal of analytical & pharmaceutical chemistry, 1 (3), 1011.
- Jacobs, R.L., et al., 2005. Physiological regulation of phospholipid methylation alters plasma homocysteine in mice. The journal of biological chemistry, 280 (31), 28299–28305. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0021925820565265
- Jain, N., 2001. Solid lipid nanoparticles. In: N.K. Jain, ed. Advances in controlled and novel drug delivery. New Delhi: CBS Publishers and Distributors, 408–425.
- Jain, S., et al., 2017. Recent advances in lipid-based vesicles and particulate carriers for topical and transdermal application. Journal of pharmaceutical sciences, 106 (2), 423–445. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0022354916417715
- Jannin, V., et al., 2015. Development of self-emulsifying lipid formulations of BCS class II drugs with low to medium lipophilicity. International journal of pharmaceutics, 495 (1), 385–392. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0378517315302076
- Jannin, V., Musakhanian, J., and Marchaud, D., 2008. Approaches for the development of solid and semi-solid lipid-based formulations. Advanced drug delivery reviews, 60 (6), 734–746. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0169409X0700316X
- Jensen, G.M. and Bunch, T.H., 2007. Conventional liposome performance and evaluation: lessons from the development of Vescan. Journal of liposome research, 17 (3–4), 121–137. Available from: 10.1080/08982100701527981
- Jetani, J.M. and Pai, K.G., 2017. A comparative review of the USFDA guidelines on process validation focusing on the importance of quality by design (QbD). Research journal of pharmacy and technology, 10 (4), 1257. Available from: http://www.indianjournals.com/ijor.aspx?target=ijor:rjpt&volume=10&issue=4&article=051
- Jiang, Y., Noh, S.K., and Koo, S.I., 2001. Egg phosphatidylcholine decreases the lymphatic absorption of cholesterol in rats. The journal of nutrition, 131 (9), 2358–2363. Available from: https://academic.oup.com/jn/article/131/9/2358/4687651
- Jin, T., Pennefather, P., and Lee, P.I., 1996. Lipobeads: a hydrogen anchored lipid vesicle system. FEBS letters, 397 (1), 70–74. Available from: 10.1016/S0014-5793%2896%2901021-6
- Jung, C.Y., 1987. [20] Erythrosomes: erythrocyte cytoskeletons coated with exogenous phospholipid as an encapsulating system, 217–221. Available from: https://linkinghub.elsevier.com/retrieve/pii/0076687987490587
- Kabalnov, A., et al., 1996. Phospholipids as emulsion stabilizers. Journal of colloid and interface science, 184 (1), 227–235. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0021979796906153
- Kalepu, S., Manthina, M., and Padavala, V., 2013. Oral lipid-based drug delivery systems – an overview. Acta pharmaceutica sinica B, 3 (6), 361–372. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2211383513000919
- Kapoor, D., et al., 2013. A multipurpose and novel carrier for drug delivery and targeting – virosomes. Journal of drug delivery and therapeutics, 3 (5), 143-147. Available from: http://jddtonline.info/index.php/jddt/article/view/627
- Kaukonen, A.M., et al., 2004. Drug solubilization behavior during in vitro digestion of simple triglyceride lipid solution formulations. Pharmaceutical research, 21 (2), 245–253. Available from: 10.1023/B:PHAM.0000016282.77887.1f
- Kazakov, S., 2017. Lipobeads. In: Liposomes. Universidad nacional de la plata, Argentina: InTech. Available from: http://www.intechopen.com/books/liposomes/lipobeads
- Kelly, K. and Jacobs, R., 2011. Phospholipid biosynthesis. Available from: http://lipidlibrary.aocs.org/Biochemistry/content.cfm?ItemNumber=39191
- Keough, K.M.W. and Davis, P.J., 1979. Gel to liquid-crystalline phase transitions in water dispersions of saturated mixed-acid phosphatidylcholines. Biochemistry, 18 (8), 1453–1459.
- Kim, S.-S., et al., 2018. Combination with SGT-53 overcomes tumor resistance to a checkpoint inhibitor. Oncoimmunology, 7 (10), e1484982. Available from: 10.1080/2162402X.2018.1484982
- Kirby, C., Clarke, J., and Gregoriadis, G., 1980. Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro. Biochemical journal, 186 (2), 591–598. Available from: https://portlandpress.com/biochemj/article/186/2/591/5396/Effect-of-the-cholesterol-content-of-small
- Kisak, E., et al., 2004. The vesosome – a multicompartment drug delivery vehicle. Current medicinal chemistry, 11 (2), 199–219. Available from: http://www.eurekaselect.com/openurl/content.php?genre=article&issn=0929-8673&volume=11&issue=2&spage=199
- Kisel, M.A., et al., 2001. Liposomes with phosphatidylethanol as a carrier for oral delivery of insulin: studies in the rat. International journal of pharmaceutics, 216 (1–2), 105–114. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0378517301005798
- Kossena, G.A., et al., 2007. Low dose lipid formulations: effects on gastric emptying and biliary secretion. Pharmaceutical research, 24 (11), 2084–2096. Available from: 10.1007/s11095-007-9363-8
- Krishna, S.V.G., Shivappa, N.N., and Vikram, S., 2019. A review on liposomes: novel drug delivery system.
- Krutmann, J., 2001. New developments in photoprotection of human skin. Skin pharmacology and physiology, 14 (6), 401–407. Available from: https://www.karger.com/Article/FullText/56374
- Kumar, A., et al., 2010. Development and characterization of liposomal drug delivery system for Nimesulide. International journal of pharmacy and pharmaceutical sciences, 2, 87–89.
- Kumar, D., et al., 2012. Lipoidal soft hybrid biocarriers of supramolecular construction for drug delivery. ISRN pharmaceutics, 2012, 1–14. Available from: https://www.hindawi.com/journals/isrn/2012/474830/
- Labiris, N.R. and Dolovich, M.B., 2003. Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications. British journal of clinical pharmacology, 56 (6), 600–612. Available from: 10.1046/j.1365-2125.2003.01893.x
- Ladbrooke, B.D. and Chapman, D., 1969. Thermal analysis of lipids, proteins and biological membranes a review and summary of some recent studies. Chemistry and physics of lipids, 3 (4), 304–356. Available from: https://linkinghub.elsevier.com/retrieve/pii/0009308469900401
- Lara, F., et al., 2003. A new intracellular pathway of haem detoxification in the midgut of the cattle tick Boophilus microplus: aggregation inside a specialized organelle, the hemosome. Journal of experimental biology, 206 (Pt 10), 1707–1715.
- Le, N.T.T., et al., 2019. Soy lecithin-derived liposomal delivery systems: surface modification and current applications. International journal of molecular science, 20 (19), 4706. Available from: https://www.mdpi.com/1422-0067/20/19/4706
- Lebedeva, A.V., et al., 2012. Experience in using injectable valproic acid (convulex) in patients with serial epileptic seizures and status epilepticus at the prehospital stage. Neurology, neuropsychiatry, psychosomatics, 4 (1S), 53. Available from: http://nnp.ima-press.net/index.php/nnp/article/view/231
- Li, F., et al., 2016. Preparation and evaluation of a self-nanoemulsifying drug delivery system loaded with Akebia saponin D-phospholipid complex. International journal of nanomedicine, 11, 4919–4929. Available from: https://www.dovepress.com/preparation-and-evaluation-of-a-self-nanoemulsifying-drug-delivery-sys-peer-reviewed-article-IJN
- Li, J., et al., 2015. A review on phospholipids and their main applications in drug delivery systems. Asian journal of pharmaceutical sciences, 10 (2), 81–98. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1818087614000725
- Lim, E.-B., Haam, S., and Lee, S.-W., 2021. Sphingomyelin-based liposomes with different cholesterol contents and polydopamine coating as a controlled delivery system. Colloids and surfaces A: physicochemical and engineering aspects, 618, 126447. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0927775721003162
- Lin, C.-C., et al., 2009. Stability and characterisation of phospholipid-based curcumin-encapsulated microemulsions. Food chemistry, 116 (4), 923–928. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0308814609003537
- Lin, Y.-L., et al., 2012. A soybean oil-based liposome-polymer transfection complex as a codelivery system for DNA and subunit vaccines. Journal of nanomaterials, 2012, 1–12. Available from: http://www.hindawi.com/journals/jnm/2012/427306/
- Liscovitch, M., et al., 2000. Phospholipase D: molecular and cell biology of a novel gene family. Biochemical journal, 345 (3), 401–415. Available from: http://www.biochemj.org/bj/345/bj3450401.htm
- Liu, D., et al., 2013. In vitro and in vivo evaluation of a water-in-oil microemulsion system for enhanced peptide intestinal delivery. The AAPS journal, 15 (1), 288–298. Available from: 10.1208/s12248-012-9441-7
- Liu, H., et al., 2015. Virosome, a hybrid vehicle for efficient and safe drug delivery and its emerging application in cancer treatment. Acta pharmaceutica, 65 (2), 105–116. Available from: 10.1515/acph-2015-0019
- Lopes, N.A. and Brandelli, A., 2018. Nanostructures for delivery of natural antimicrobials in food. Critical reviews in food science and nutrition, 58 (13), 2202–2212. Available from: 10.1080/10408398.2017.1308915
- Lv, Z., Zhu, Y., and Li, F., 2021. DNA functional nanomaterials for controlled delivery of nucleic acid-based drugs. Frontieris in bioengineering and biotechnology, 9, 720291. Available from: 10.3389/fbioe.2021.720291/full
- Ma, B., et al., 2007. Lipoplex morphologies and their influences on transfection efficiency in gene delivery. Journal of controlled release, 123 (3), 184–194. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0168365907004312
- Mach, M., et al., 2020. The influence of cationic lipoid – 1-palmitoyl-2-oleoyl-sn-glycero-3-ethylphosphocholine – on model lipid membranes. Biochimica et biophysica acta (BBA)-biomembranes, 1862 (2), 183088. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0005273619302342
- Martins, S., et al., 2007. Lipid-based colloidal carriers for peptide and protein delivery–liposomes versus lipid nanoparticles. International journal of nanomedicine, 2 (4), 595–607.
- Mastrobattista, E., Koning, G.A., and Storm, G., 1999. Immunoliposomes for the targeted delivery of antitumor drugs. Advanced drug delivery reviews, 40 (1–2), 103–127. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0169409X99000435
- McClements, D.J., 2021. Advances in edible nanoemulsions: digestion, bioavailability, and potential toxicity. Progress in lipid research, 81, 101081. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0163782720300618
- McElhaney, R.N., 1982. The use of differential scanning calorimetry and differential thermal analysis in studies of model and biological membranes. Chemistry and physics of lipids, 30 (2–3), 229–259. Available from: https://linkinghub.elsevier.com/retrieve/pii/0009308482900536
- Meagher, R.B., et al., 2021. Aiming for a bull's-eye: targeting antifungals to fungi with dectin-decorated liposomes. PLOS pathogens, 17 (7), e1009699. Available from: 10.1371/journal.ppat.1009699
- Mehta, K., et al., 1994. Liposome encapsulation circumvents the hepatic clearance mechanisms of all-trans-retinoic acid. Leukemia research, 18 (8), 587–596. Available from: https://linkinghub.elsevier.com/retrieve/pii/014521269490040X
- Mercuri, A.M., 2016. Quality by design applied to ocular solid lipid nanoparticles containing a hydrophilic peptide prepared via hot high pressure homogeniser. Current drug delivery, 13 (8), 1247–1260. Available from: http://www.eurekaselect.com/openurl/content.php?genre=article&issn=1567-2018&volume=13&issue=8&spage=1247
- Merrill, A.H., 2011. Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics. Chemical reviews, 111 (10), 6387–6422. Available from: 10.1021/cr2002917
- Miere, (Groza) F., et al., 2021. Preparation and characterization of two different liposomal formulations with bioactive natural extract for multiple applications. Processes, 9 (3), 432. Available from: https://www.mdpi.com/2227-9717/9/3/432
- Mirza, S., et al., 2010. Enhanced dissolution and oral bioavailability of piroxicam formulations: modulating effect of phospholipids. Pharmaceutics, 2 (4), 339–350. Available from: http://www.mdpi.com/1999-4923/2/4/339
- Mischler, R., and Metcalfe, I.C., 2002. Inflexal®V a trivalent virosome subunit influenza vaccine: production. Vaccine, 20, B17–B23. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0264410X02005121
- Mishra, D.K., Shandilya, R., and Mishra, P.K., 2018. Lipid based nanocarriers: a translational perspective. Nanomedicine nanotechnology, biology and medicine, 14 (7), 2023–2050. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1549963418304787
- Mohammady, S.Z., Pouzot, M., and Mezzenga, R., 2009. Oleoylethanolamide-based lyotropic liquid crystals as vehicles for delivery of amino acids in aqueous environment. Biophysical journal, 96 (4), 1537–1546. Available from: https://linkinghub.elsevier.com/retrieve/pii/S000634950803227X
- Mohan, G., 2014. Lipid based drug delivery system: classification, drug transport across enterocyte, role of lipid chain length in suppression of body fat accumulation.
- Mohanty, D., et al., 2018. Ethosomes: a novel approach for transdermal drug delivery. International journal of chemtech research, 11 (8), 219–226.
- Mostafa, D. M., Abd El-Alim, S. H., and Kassem, A. A., 2017. Nanoemulsions. In: Nanotechnology applications in food. Politehnica University of Bucharest, Romania: Elsevier, 107–127. Available from: https://linkinghub.elsevier.com/retrieve/pii/B9780128119426000066
- Moussaoui, N., Cansell, M., and Denizot, A. 2002. Marine lipid-based liposomes: physical characterization and potential application in cosmetics. International journal of pharmaceutics, 242 (1–2), 361–365. Available from: https://linkinghub.elsevier.com/retrieve/pii/S037851730200217X
- Mu, H. and Porsgaard, T., 2005. The metabolism of structured triacylglycerols. Progress in lipid research, 44 (6), 430–448. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0163782705000391
- Nagy, J.O., et al., 2017. Compositions and methods for treating ewing sarcoma. Unitated States; US20170143630A1.
- Nainwal, N., et al., 2019. Transdermal applications of ethosomes – a detailed review. Journal of liposome research, 29 (2), 103–113. Available from: 10.1080/08982104.2018.1517160
- Nair, A.J., et al., 2014. Ufasome: a potential phospholipid carrier as a novel pharmaceutical formulation. International research journal of pharmacy, 5 (4), 250–253. Available from: http://www.irjponline.com/admin/php/uploads/2145_pdf.pdf
- Najlah, M., et al., 2019. Development of injectable PEGylated liposome encapsulating disulfiram for colorectal cancer treatment. Pharmaceutics, 11 (11), 610. Available from: https://www.mdpi.com/1999-4923/11/11/610
- Nakanishi, M., 2001. Confocal and probe microscopy to study gene transfection mediated by cationic liposomes with a cationic cholesterol derivative. Advanced drug delivery reviews, 52 (3), 197–207. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0169409X01002071
- Nanjwade, B.K., 2015. Nanomedicine to tumor by enzymosomes. Nanotechnology: nanomedicine & nanobiotechnology, 2 (1), 1–5. Available from: http://www.heraldopenaccess.us/fulltext/Nanotechnology-Nanomedicine-&-Nanobiotechnology/Nanomedicine-to-Tumor-by-Enzymosomes.php
- Nawale, R.B., et al., 2017. Formulation and characterization of efavirenz nanosuspension by QbD approach. Research journal of pharmacy and technology, 10 (9), 2960. Available from: http://www.indianjournals.com/ijor.aspx?target=ijor:rjpt&volume=10&issue=9&article=025
- Nir, S., Düzgüneş, N., and Bentz, J., 1983. Binding of monovalent cations to phosphatidylserine and modulation of Ca2+- and Mg2+-induced vesicle fusion. Biochimica et biophysica acta (BBA)-biomembranes, 735 (1), 160–172. Available from: https://linkinghub.elsevier.com/retrieve/pii/0005273683902717
- Obuobi, S., et al., 2020. Liposomal delivery of antibiotic loaded nucleic acid nanogels with enhanced drug loading and synergistic anti-inflammatory activity against S. aureus intracellular infections. Journal of controlled release, 324, 620–632. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0168365920303345
- Ohanian, M., et al., 2018. Liposomal Grb2 antisense oligodeoxynucleotide (BP1001) in patients with refractory or relapsed haematological malignancies: a single-centre, open-label, dose-escalation, phase 1/1b trial. The lancet. Haematology, 5 (4), e136–e146. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2352302618300218
- Olusanya, T., et al., 2018. Liposomal drug delivery systems and anticancer drugs. Molecules, 23 (4), 907. Available from: http://www.mdpi.com/1420-3049/23/4/907
- Opatha, S.A.T., Titapiwatanakun, V., and Chutoprapat, R., 2020. Transfersomes: a promising nanoencapsulation technique for transdermal drug delivery. Pharmaceutics, 12 (9), 855. Available from: https://www.mdpi.com/1999-4923/12/9/855
- Paleos, C.M., et al., 2013. Formation of artificial multicompartment vesosome and dendrosome as prospected drug and gene delivery carriers. Journal of controlled release, 170 (1), 141–152. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0168365913002721
- Pandita, A. and Sharma, P., 2013. Pharmacosomes: an emerging novel vesicular drug delivery system for poorly soluble synthetic and herbal drugs. ISRN pharmaceutics, 2013, 1–10. Available from: https://www.hindawi.com/journals/isrn/2013/348186/
- Papahadjopoulos, D., et al., 1974. Membrane fusion and molecular segregation in phospholipid vesicles. Biochimica et biophysica acta (BBA)-biomembranes, 352 (1), 10–28. Available from: https://linkinghub.elsevier.com/retrieve/pii/0005273674901758
- Patel, D., Patel, C., and Jani, R., 2011. Ufasomes: a vesicular drug delivery. Systematic reviews in pharmacy, 2 (2), 72. Available from: http://www.sysrevpharm.org/text.asp?2011/2/2/72/86290
- Patel, G.B., and Sprott, G.D., 1999. Archaeobacterial ether lipid liposomes (archaeosomes) as novel vaccine and drug delivery systems. Critical reviews in biotechnology, 19 (4), 317–357. Available from: 10.1080/0738-859991229170
- Patel, G.B., et al., 2000. In vitro assessment of archaeosome stability for developing oral delivery systems. International journal of pharmaceutics, 194 (1), 39–49. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0378517399003312
- Pfennig, A., 1996. KIRK-OTHMER. Encyclopedia of Chemical Technology. Vol. 13, Fourth Edition. John Wiley, Chichester 1995. 1100 Seiten mit zahlr. Abb. u. Tab., £195,-. ISBN 0-471-52682-7. Chemie ingenieur technik, 68 (7), 850–850. Available from: 10.1002/cite.330680721
- Pichot, R., Watson, R., and Norton, I., 2013. Phospholipids at the interface: current trends and challenges. International journal of molecular science, 14 (6), 11767–11794. Available from: http://www.mdpi.com/1422-0067/14/6/11767
- Pignatello, R., Nicolosi, D., and Nicolosi, V., 2011. Fusogenic liposomes as new carriers to enlarge the spectrum of action of antibiotic drugs against Gram-negative bacteria.
- Porfire, A., et al., 2017. A quality by design approach for the development of lyophilized liposomes with simvastatin. Saudi pharmaceutical journal, 25 (7), 981–992. Available from: https://linkinghub.elsevier.com/retrieve/pii/S131901641730021X
- Porter, C.J. and Charman, W.N., 2001. In vitro assessment of oral lipid based formulations. Advanced drug delivery reviews, 50, S127–S47. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0169409X0100182X
- Porter, C.J.H., et al., 2004. Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine. Journal of pharmaceutical sciences, 93 (5), 1110–1121. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0022354916315076
- Porter, C.J.H., Trevaskis, N.L., and Charman, W.N., 2007. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nature reviews. Drug discovery, 6 (3), 231–248. Available from: http://www.nature.com/articles/nrd2197
- Pouton, C.W., 2000. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and ‘self-microemulsifying’ drug delivery systems. European journal of pharmaceutical sciences, 11, S93–S98. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0928098700001676
- Pouton, C.W., 2006. Formulation of poorly water-soluble drugs for oral administration: Physicochemical and physiological issues and the lipid formulation classification system. European journal of pharmaceutical sciences, 29 (3–4), 278–287. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0928098706001151
- Prabhu, P., et al., 2012. Investigation of nano lipid vesicles of methotrexate for anti-rheumatoid activity. International journal of nanomedicine, 7, 177–186. Available from: http://www.dovepress.com/investigation-of-nano-lipid-vesicles-of-methotrexate-for-anti-rheumato-peer-reviewed-article-IJN
- Price, R. and Patchan, M., 1991. Controlled release from cylindrical microstructures. Journal of microencapsulation, 8 (3), 301–306. Available from: 10.3109/02652049109069556
- Quinn, P.J., 2010. A lipid matrix model of membrane raft structure. Progress in lipid research, 49 (4), 390–406. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0163782710000275
- Rajabalaya, R., et al., 2017. Oral and transdermal drug delivery systems: role of lipid-based lyotropic liquid crystals. Drug design, development and therapy, 11, 393–406. Available from: https://www.dovepress.com/oral-and-transdermal-drug-delivery-systems-role-of-lipid-based-lyotrop-peer-reviewed-article-DDDT
- Rajendran, V., et al., 2015. Stearylamine liposomal delivery of monensin in combination with free artemisinin eliminates blood stages of Plasmodium falciparum in culture and P. berghei infection in murine malaria. Antimicrobial agents and chemotherapy, 60 (3), 1304–1318. Available from: 10.1128/AAC.01796-15
- Raju, K., et al., 2020. Vesosomes: new prospects in multi compartment vesicular drug delivery system. International journal of pharmaceutical research, 12 (1), 869-877. Available from: http://ijpronline.com/ViewArticleDetail.aspx?ID=12627
- Ramasamy, T., et al., 2008. Nanocochleate – a new drug delivery system. FABAD journal of pharmaceutical sciences, 34, 91-101.
- Ramstedt, B. and Slotte, J.P., 2002. Membrane properties of sphingomyelins. FEBS letters, 531 (1), 33–37. Available from: 10.1016/S0014-5793%2802%2903406-3
- Rana, H.B., et al., 2018. Development of sustained release pellets of galantamine HBr by extrusion spheronization technique incorporating risk based QbD approach. Research journal of pharmacy and technology, 11 (11), 4899. Available from: http://www.indianjournals.com/ijor.aspx?target=ijor:rjpt&volume=11&issue=11&article=024
- Rane, S.S. and Anderson, B.D., 2008. What determines drug solubility in lipid vehicles: is it predictable? Advanced drug delivery reviews, 60 (6), 638–656. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0169409X07003110
- Rao, S., et al., 2014. Perspective and potential of oral lipid-based delivery to optimize pharmacological therapies against cardiovascular diseases. Journal of controlled release, 193, 174–187. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0168365914003162
- Rathore, S.S. and Ghosh, P.C., 2008. Effect of surface charge and density of distearylphosphatidylethanolamine-mPEG-2000 (DSPE-mPEG-2000) on the cytotoxicity of liposome-entrapped ricin: effect of lysosomotropic agents. International journal of pharmaceutics, 350 (1–2), 79–94. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0378517307007041
- Reiss-Husson, F. and Luzzati, V., 1964. The structure of the micellar solutions of some amphiphilic compounds in pure water as determined by absolute small-angle X-ray scattering techniques. The journal of physical chemistry, 68 (12), 3504–3511. Available from: 10.1021/j100794a011
- Rodríguez-Pulido, A., et al., 2008. Compaction process of calf thymus DNA by mixed cationic-zwitterionic liposomes: a physicochemical study. The journal of physical chemistry. B, 112 (7), 2187–2197. Available from: 10.1021/jp7095828
- Roh, Y.H., et al., 2011. DNAsomes: multifunctional DNA-based nanocarriers. Small, 7 (1), 74–78. Available from: 10.1002/smll.201000752
- Rupp, C., Steckel, H., and Müller, B.W., 2010. Mixed micelle formation with phosphatidylcholines: the influence of surfactants with different molecule structures. International journal of pharmaceutics, 387 (1–2), 120–128. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0378517309008758
- Sabín, J., et al., 2009. Interactions between DMPC liposomes and the serum blood proteins HSA and IgG. The journal of physical chemistry. B, 113 (6), 1655–1661. Available from: 10.1021/jp804641e
- Sankar, C., et al., 2019. Formulation and characterization of liposomes containing clindamycin and green tea for anti-acne. Research journal of pharmacy and technology, 12 (12), 5977. Available from: http://www.indianjournals.com/ijor.aspx?target=ijor:rjpt&volume=12&issue=12&article=061
- Saraf, S., et al., 2010. Colloidosomes an advanced vesicular system in drug delivery. Asian journal of scientific research, 4 (1), 1–15. Available from: https://www.scialert.net/abstract/?doi=ajsr.2011.1.15
- Saraf, S., et al., 2011. Sphingosomes A novel approach to vesicular drug delivery. Research journal of pharmacy and technology, 4 (5), 661–666.
- Sarker, D., et al., 2020. MTL-CEBPA, a small activating RNA therapeutic upregulating C/EBP-α, in patients with advanced liver cancer: a first-in-human, multicenter, open-label, phase I trial. Clinical cancer research, 26 (15), 3936–3946. Available from: 10.1158/1078-0432.CCR-20-0414
- Savla, R., et al., 2017. Review and analysis of FDA approved drugs using lipid-based formulations. Drug development and industrial pharmacy, 43 (11), 1743–1758. Available from: 10.1080/03639045.2017.1342654
- Sek, L., et al., 2010. Evaluation of the in-vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic products. Journal of pharmacy and pharmacology, 54 (1), 29–41. Available from: https://academic.oup.com/jpp/article/54/1/29/6150092
- Semalty, A., et al., 2009. Pharmacosomes: the lipid-based new drug delivery system. Expert opinion on drug delivery, 6 (6), 599–612. Available from: 10.1517/17425240902967607
- Senior, J., Crawley, J.C.W., and Gregoriadis, G., 1985. Tissue distribution of liposomes exhibiting long half-lives in the circulation after intravenous injection. Biochimica et biophysica acta (BBA)-general subjects, 839 (1), 1–8. Available from: https://linkinghub.elsevier.com/retrieve/pii/0304416585901746
- Senzer, N., et al., 2012. 51. Results of a phase I trial of SGT-53: a systemically administered, tumor-targeting immunoliposome nanocomplex incorporating a plasmid encoding wtp53. Molecular therapy, 20, S21. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1525001616358555
- Sercombe, L., et al., 2015. Advances and challenges of liposome assisted drug delivery. Frontiers in pharmacology, 6, 286. Available from: 10.3389/fphar.2015.00286
- Sethia, S. and Squillante, E., 2004. In vitro-in vivo evaluation of supercritical processed solid dispersions: permeability and viability assessment in Caco-2 cells. Journal of pharmaceutical sciences, 93 (12), 2985–2993. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0022354916393169
- Shah, P., Bhalodia, D., and Shelat, P., 2010. Nanoemulsion: a pharmaceutical review. Systematic reviews in pharmacy, 1 (1), 24. Available from: http://www.sysrevpharm.org/text.asp?2010/1/1/24/59509
- Shaikh, S.N., et al., 2019. Overview on virosomes as a novel carrier for drug delivery. Journal of drug delivery and therapeutics, 8 (6-s), 429–434. Available from: http://jddtonline.info/index.php/jddt/article/view/2163
- Shefrin, S., et al., 2017. Enzymosomes: a rising effectual tool for targeted drug delivery system. International Journal of Applied Pharmaceutics, 9 (6), 1. Available from: https://innovareacademics.in/journals/index.php/ijap/article/view/22556
- Shen, J. and Burgess, D.J., 2015. In vitro-in vivo correlation for complex non-oral drug products: where do we stand? Journal of controlled release, 219, 644–651. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0168365915301528
- Shilpi, S., et al., 2007. Colloidosomes: an emerging vesicular system in drug delivery. Critical reviews in therapeutic drug carrier systems, 24 (4), 361–391. Available from: http://www.dl.begellhouse.com/journals/3667c4ae6e8fd136,399f9d471c1c74e4,51f2cab7582ecda0.html
- Simovic, S., et al., 2012. Assembling nanoparticle coatings to improve the drug delivery performance of lipid based colloids. Nanoscale, 4 (4), 1220–1230. Available from: http://xlink.rsc.org/?DOI=C1NR11273B
- Singh, A., Malviya, R., and Sharma, P., 2011. Novasome-A breakthrough in pharmaceutical technology a review article. Advances in biological research, 5, 184–189.
- Singh, B., et al., 2009. Self-emulsifying drug delivery systems (SEDDS): formulation development, characterization, and applications. Critical reviews in therapeutic drug carrier systems, 26 (5), 427–451. Available from: http://www.dl.begellhouse.com/journals/3667c4ae6e8fd136,7bc13fbe52b73e32,3ecc45285b4b6014.html
- Singh, R., Upadhayay, A., and Kale, M.K., 2018. Effect of liposomes as a carrier on pharmacokinetics of cisplatin. Research journal of pharmacy and technology, 11 (11), 5073. Available from: http://www.indianjournals.com/ijor.aspx?target=ijor:rjpt&volume=11&issue=11&article=057
- Singh, S. and Sharma, D.R., 1999. A review of absorption characteristics of microemulsion cyclosporine products over the last 2 years in Indian subjects. Journal of Indian Medical Association, 97 (3), 114–117. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10652912
- Siram, K., et al., 2019. Pharmaceutical nanotechnology: brief perspective on lipid drug delivery and its current scenario. In: Biomedical applications of nanoparticles. University Politehnica of Bucharest, Romania: Elsevier, 91–115. Available from: https://linkinghub.elsevier.com/retrieve/pii/B978012816506500005X
- Smolders, L., et al., 2019. Natural choline from egg yolk phospholipids is more efficiently absorbed compared with choline bitartrate; outcomes of a randomized trial in healthy adults. Nutrients, 11 (11), 2758. Available from: https://www.mdpi.com/2072-6643/11/11/2758
- Spargo, B.J., et al., 1995. Controlled release of transforming growth factor-beta from lipid-based microcylinders. Journal of microencapsulation, 12 (3), 247–254. Available from: 10.3109/02652049509010293
- Sprott, G.D., Patel, G.B., and Krishnan, L., 2003. Archaeobacterial ether lipid liposomes as vaccine adjuvants, 155–72. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0076687903730110
- Stege, H., 2001. Effect of xenogenic repair enzymes on photoimmunology and photocarcinogenesis. Journal of photochemistry and photobiology B: biology, 65 (2–3), 105–108. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1011134401002469
- Stone, N.R.H., et al., 2016. Liposomal amphotericin B (AmBisome(®)): a review of the pharmacokinetics, pharmacodynamics, clinical experience and future directions. Drugs, 76 (4), 485–500. Available from: 10.1007/s40265-016-0538-7
- Supraja, B. and Mulangi, S., 2019. An updated review on pharmacosomes, a vesicular drug delivery system. Journal of drug delivery and therapeutics, 9 (1-s), 393–402. Available from: http://jddtonline.info/index.php/jddt/article/view/2234
- Talegaonkar, S., et al., 2006. Vesicular systems: an overview. Indian journal of pharmaceutical sciences, 68 (2), 141. Available from: http://www.ijpsonline.com/text.asp?2006/68/2/141/25707
- Tam, Y., Chen, S., and Cullis, P., 2013. Advances in lipid nanoparticles for siRNA delivery. Pharmaceutics, 5 (4), 498–507. Available from: http://www.mdpi.com/1999-4923/5/3/498
- Tardi, P., Boman, N., and Cullis, P., 1996. Liposomal doxorubicin. Journal of drug targeting, 4 (3), 129–140. Available from: 10.3109/10611869609015970
- Teja, S.P.S. and Damodharan, N., 2018. 23 Full factorial model for particle size optimization of methotrexate loaded chitosan nanocarriers: a design of experiments (DoE) approach. BioMed research international, 2018, 1–9. Available from: https://www.hindawi.com/journals/bmri/2018/7834159/
- Tiemessen, H., van Hoogevest, P., and Leigh, M.L.S., 2004. Characteristics of a novel phospholipid-based depot injectable technology for poorly water-soluble drugs. European journal of pharmaceutics and biopharmaceutics, 58 (3), 587–593. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0939641104001031
- Trapnell, C.B., 1998. Saquinavir as Fortovase: why does it matter? AIDS clinical care, 10 (5), 40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11365428
- Ueno, M., et al., 1990. Evaluation of phase transition temperature of liposomes by using the tautomerism of α-benzoylacetoanilide. Journal of colloid and interface science, 134 (2), 589–592. Available from: https://linkinghub.elsevier.com/retrieve/pii/002197979090167M
- Ugwu, S., et al., 2005. Preparation, characterization, and stability of liposome-based formulations of mitoxantrone. Drug development and industrial pharmacy, 31 (2), 223–229. Available from: 10.1081/DDC-200047850
- US Compendial Nomenclature, 2022. Available from: https://www.usp.org/health-quality-safety/compendial-nomenclature
- Valenta, C., 2003. Permeation of cyproterone acetate through pig skin from different vehicles with phospholipids. International journal of pharmaceutics, 258 (1–2), 133–139. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0378517303001807
- van Hoogevest, P. and Wendel, A., 2014. The use of natural and synthetic phospholipids as pharmaceutical excipients. European journal of lipid science and technology, 116 (9), 1088–1107. Available from: 10.1002/ejlt.201400219
- van Hoogevest, P., 2017. Review – an update on the use of oral phospholipid excipients. European journal of pharmaceutical sciences, 108, 1–12. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0928098717304074
- van Staden, D., du Plessis, J., and Viljoen, J., 2020. Development of topical/transdermal self-emulsifying drug delivery systems, not as simple as expected. Scientia pharmaceutica, 88 (2), 17. Available from: https://www.mdpi.com/2218-0532/88/2/17
- Venkatesan, N., et al., 2006. Pharmacokinetic and pharmacodynamic studies following oral administration of erythropoietin mucoadhesive tablets to beagle dogs. International journal of pharmaceutics, 310 (1–2), 46–52. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0378517305007581
- Verma, D. and Fahr, A., 2004. Synergistic penetration enhancement effect of ethanol and phospholipids on the topical delivery of cyclosporin A. Journal of controlled release, 97 (1), 55–66. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0168365904000987
- Vyas, S.P., Subhedar, R., and Jain, S., 2010. Development and characterization of emulsomes for sustained and targeted delivery of an antiviral agent to liver. Journal of pharmacy and pharmacology, 58 (3), 321–326. Available from: https://academic.oup.com/jpp/article/58/3/321/6147718
- Wagner, A. and Vorauer-Uhl, K., 2011. Liposome technology for industrial purposes. Journal of drug delivery, 2011, 1–9. Available from: https://www.hindawi.com/journals/jdd/2011/591325/
- Wang, D.-Y., et al., 2020. Lipid-based antimicrobial delivery-systems for the treatment of bacterial infections. Frontiers in chemistry, 7, 872. Available from: 10.3389/fchem.2019.00872/full
- Wang, G., et al., 2015. Advances in lipid-based drug delivery: enhancing efficiency for hydrophobic drugs. Expert opinion on drug delivery, 12 (9), 1475–1499. Available from: 10.1517/17425247.2015.1021681
- Wang, L., Hu, C., and Shao, L., 2017. The antimicrobial activity of nanoparticles: present situation and prospects for the future. International journal of nanomedicine, 12, 1227–1249. Available from: https://www.dovepress.com/the-antimicrobial-activity-of-nanoparticles-present-situation-and-pros-peer-reviewed-article-IJN
- Weigert, R., et al., 1999. CtBP/BARS induces fission of Golgi membranes by acylating lysophosphatidic acid. Nature, 402 (6760), 429–433. Available from: http://www.nature.com/articles/46587
- WHO, 1973. WHO food additives series No. 5. Available from: http://www.inchem.org/documents/jecfa/jecmono/v05je42.htm
- Wirtz, K.W.A., 1991. Phospholipid transfer proteins. Annual review of biochemistry, 60 (1), 73–99. Available from: 10.1146/annurev.bi.60.070191.000445
- Wolfmeier, H., et al., 2018. New perspectives in biofilm eradication. ACS Infectious Diseases, 4 (2), 93–106. Available from: 10.1021/acsinfecdis.7b00170
- Woodle, M.C. and Papahadjopoulos, D., 1989. [9] Liposome preparation and size characterization, 193–217. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0076687989710120
- Xu, X., Khan, M.A., and Burgess, D.J., 2011. A quality by design (QbD) case study on liposomes containing hydrophilic API: I. Formulation, processing design and risk assessment. International journal of pharmaceutics, 419 (1–2), 52–59. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0378517311006417
- Xu, X., Khan, M.A., and Burgess, D.J., 2012. A quality by design (QbD) case study on liposomes containing hydrophilic API: II. Screening of critical variables, and establishment of design space at laboratory scale. International journal of pharmaceutics, 423 (2), 543–553. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0378517311010775
- Xu, Y., Yuen, P.-W., and Lam, J., 2014. Intranasal DNA vaccine for protection against respiratory infectious diseases: the delivery perspectives. Pharmaceutics, 6 (3), 378–415.
- Yager, P. and Schoen, P.E., 1984. Formation of tubules by a polymerizable surfactant. Molecular crystals and liquid crystals, 106 (3–4), 371–381. Available from: 10.1080/00268948408071454
- Yamamoto, S., et al., 2019. Solubilization of genistein in phospholipid vesicles and their atioxidant capacity. Journal of Oleo Science, 68 (1), 61–66. Available from: https://www.jstage.jst.go.jp/article/jos/68/1/68_ess18181/_article
- Yan, R., et al., 2017. Simultaneous determination of tricaprylin, DPPG and DEPC in propofol liposomes by a methyl esterification method and GC-FID analysis. Analytical methods, 9 (35), 5101–5107. Available from: http://xlink.rsc.org/?DOI=C7AY00592J
- Yeh, Y.-C., et al., 2020. Nano-based drug delivery or targeting to eradicate bacteria for infection mitigation: a review of recent advances. Frontiers in chemistry, 8, 286. Available from: 10.3389/fchem.2020.00286/full
- Yeo, S., et al., 2020. Design and characterization of phosphatidylcholine-based solid dispersions of aprepitant for enhanced solubility and dissolution. Pharmaceutics, 12 (5), 407. Available from: https://www.mdpi.com/1999-4923/12/5/407
- Zhang, X., et al., 2018. Pharmaceutical dispersion techniques for dissolution and bioavailability enhancement of poorly water-soluble drugs. Pharmaceutics, 10 (3), 74. Available from: http://www.mdpi.com/1999-4923/10/3/74
- Zheng, N., et al., 2014. Bioequivalence for liposomal drug products, 275–96. Available from: 10.1007/978-1-4939-1252-0_11
- Zhu, X., et al., 2013. Formulation and evaluation of lidocaine base ethosomes for transdermal delivery. Anesthesia & analgesia, 117 (2), 352–357. Available from: https://journals.lww.com/00000539-201308000-00011
- Zoubari, G., et al., 2017. Effect of drug solubility and lipid carrier on drug release from lipid nanoparticles for dermal delivery. European journal of pharmaceutics and biopharmaceutics, 110, 39–46. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0939641116307585